GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today published a paper in Nature Methods, titled "Multiscale analysis of pangenomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback